THE COST-EFFECTIVENESS AND COST-UTILITY OF PALIPERIDONE PALMITATE IN THE TREATMENT OF SCHIZOPHRENIA IN GUATEMALA

被引：1
|
作者：
Obando, C. A. [1 ]
Gonzalez, L. [2 ]
Muschett, D. [1 ]
机构：
[1] Janssen, Panama City, Panama
[2] Janssen, Raritan, NJ USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.2089
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A695 / A695
页数：1
相关论文
共 50 条
  • [31] Cost-utility and cost-effectiveness of physical exercise during adjuvant chemotherapy
    van Waart, Hanna
    van Dongen, Johanna M.
    van Harten, Wim H.
    Stuiver, Martijn M.
    Huijsmans, Rosalie
    Hellendoorn-van Vreeswijk, Jeannette A. J. H.
    Sonke, Gabe S.
    Aaronson, Neil K.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (06): : 893 - 904
  • [32] A Review on Cost-Effectiveness and Cost-Utility of Psychosocial Care in Cancer Patients
    Jansen, Femke
    van Zwieten, Valesca
    Coupe, Veerle M. H.
    Leemans, C. Rene
    Leeuw, Irma M. Verdonck-de
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2016, 3 (02) : 125 - 136
  • [33] Posttransplant Hepatocellular Carcinoma Surveillance A Cost-effectiveness and Cost-utility Analysis
    Hessheimer, Amelia J.
    Vargas-Martinez, Ana Magdalena
    Trapero-Bertran, Marta
    Navasa, Miquel
    Fondevila, Constantino
    ANNALS OF SURGERY, 2023, 277 (02) : E359 - E365
  • [34] Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson's Disease
    Verschuur, Constant V. M.
    Suwijn, Sven R.
    de Haan, Rob J.
    Boel, Judith A.
    Post, Bart
    Bloem, Bas R.
    van Hilten, Johannes J.
    van Laar, Teus
    Tissingh, Gerrit
    Munts, Alexander
    Dijkgraaf, Marcel G. W.
    de Bie, Rob M. A.
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (07) : 2171 - 2178
  • [35] The Cost-Effectiveness and Cost-Utility of Statin Drug for the Treatment of Patients with Cardiovascular Disease, A Systematic Review
    Eisavi, Mahmoud
    Mazaheri, Elaheh
    Rezapour, Aziz
    Vahedi, Sajad
    Hadian, Marziye
    Jafari, Abdosaleh
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2021, 12 (01)
  • [36] Treatment of chronic atrial fibrillation with warfarin or aspirin: A cost-effectiveness and cost-utility analysis.
    Zarnke, KB
    Levine, MAH
    OBrien, B
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PII89 - PII89
  • [37] BELIMUMAB FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN GRECE: A COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS
    Athanasakis, K.
    Karampli, E.
    Ollandezos, M.
    Igoumenidis, M.
    Karabela, P.
    Psomali, D.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2014, 17 (07) : A532 - A532
  • [38] COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS OF BELIMUMAB FOR THE TREATMENT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN PORTUGAL
    Gouveia, M.
    Borges, M.
    Augusto, M.
    Costa, J.
    Treur, M.
    Lopes, S.
    VALUE IN HEALTH, 2013, 16 (07) : A384 - A384
  • [39] The cost-effectiveness of screening and treatment for hepatitis C in prisons in England and Wales: a cost-utility analysis
    Sutton, A. J.
    Edmunds, W. J.
    Sweeting, M. J.
    Gill, O. N.
    JOURNAL OF VIRAL HEPATITIS, 2008, 15 (11) : 797 - 808
  • [40] Trabectedin in the treatment of metastatic soft tissue sarcoma: cost-effectiveness, cost-utility and value of information
    Soini, E. J. O.
    Garcia San Andres, B.
    Joensuu, T.
    ANNALS OF ONCOLOGY, 2011, 22 (01) : 215 - 223
12345